Use of infrared thermography to estimate brown fat activation after a cooling protocol in patients with severe obesity that underwent bariatric surgery by Piquer García, Irene et al.
1 
 
 Use of infrared thermography to estimate brown fat activation after a cooling protocol 
in patients with severe obesity that underwent bariatric surgery 
 
Short title: Brown adipose tissue after bariatric surgery 
 
Irene Piquer-Garcia1, Rubén Cereijo2,3, Juan Corral-Pérez4,5, Silvia Pellitero1,6, Eva Martínez1, Siri 
D. Taxerås1, Jordi Tarascó1, Pau Moreno1, José Balibrea7, Manel Puig-Domingo1,6, Dolors 
Serra3,8, Laura Herrero3,8, David Jiménez-Pavón4,5, Carles Lerin9, Francesc Villarroya2,3, 
David Sánchez-Infantes1,3* 
1Germans Trias i Pujol Research Institute, Barcelona, Spain 
2Department of Biochemistry and Molecular Biomedicine, and Institute of Biomedicine, 
University of Barcelona, Barcelona, Spain. 
3Centro de Investigación Biomédica de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), 
Instituto de Salud Carlos III, E-28029 Madrid, Spain. 
4MOVE-IT Research Group and Department of Physical Education, Faculty of Education Sciences 
University of Cádiz, Cádiz, Spain. 
5Institute of Research and Innovation in Biomedical Sciences of the Province of Cádiz (INiBICA), 
University of Cádiz, Cádiz, Spain. 
6Centro de Investigación Biomédica en Fisiopatología de la Diabetes y enfermedades 
metabólicas (CIBERDEM), ISCIII, Madrid, Spain. 
7Metabolic and Bariatric Surgery Unit, EAC-BS Center of Excellence, Vall d'Hebron University 
Hospital, Barcelona, Spain. 
8Department of Biochemistry and Physiology, School of Pharmacy, Institut de Biomedicina de la 
Universitat de Barcelona (IBUB), Universitat de Barcelona, E-08028 Barcelona, Spain 
9 Endocrinology department, Institut de Recerca Sant Joan de Déu, 08950 Barcelona, Spain. 
 
*Correspondence: 
David Sánchez-Infantes, PhD dsanchez@igtp.cat 
Germans Trias i Pujol Research Institute (IGTP)  
Campus Can Ruti. Carretera de Can Ruti, Camí de les Escoles s/n 
08916 Badalona, Barcelona, Spain  Tel: (+34) 93 557 2832 Fax: (+34) 93 497 8654 
 
Acknowledgement 
Samples from patients included in this study were provided by the IGTP HUGTP Biobank 




(PT13/0010/0009) and they were processed following standard operating procedures with the 
appropriate approval of the Ethical and Scientific Committees.  
  
Funding agencies: 
DS-I is an Investigator of the Miguel Servet Fund from Carlos III National Institute of 
Health, Spain (CP15/00106). This study was supported by Instituto de Salud Carlos III, and by the 
Fondo Europeo de Desarrollo Regional (FEDER), Madrid, Spain (FIS17/01455) and by K-sted 
651010-Project number 70084900-analyse number M50676 from Norwegian University of 
Science and Technology (NTNU). DJP was supported by a grant from the Spanish Ministry of 
Science and Innovation - MINECO (RYC-2014-16938). This study was supported by the Ministry 
of Spain (MINECO) (Grant SAF2017-83813-C3-1-R to DS and LH cofunded by the European 
Regional Development Fund [ERDF]), the Centro de Investigación Biomédica en Red de 
Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) (Grant CB06/03/0001 to DS), and the 
Fundació La Marató de TV3 (Grant 87/C/2016 to DS). 
 
COI statement: 
Irene Piquer-Garcia has nothing to disclose. 
Rubén Cereijo has nothing to disclose. 
Juan Corral-Pérez has nothing to disclose. 
Silvia Pellitero has nothing to disclose. 
Eva Martínez has nothing to disclose. 
Siri D. Taxerås has nothing to disclose. 
Jordi Tarascó has nothing to disclose. 
Pau Moreno has nothing to disclose. 
José Balibrea has nothing to disclose. 
Manel Puig-Domingo has nothing to disclose. 
Dolors Serra has nothing to disclose. 
Laura Herrero has nothing to disclose. 
David Jiménez-Pavón has nothing to disclose. 
Carles Lerin has nothing to disclose. 
Francesc Villarroya reports grants from Ministerio de Ciencia, Innovació y Universidades, outside 
the submitted work. 
David Sánchez-Infantes has nothing to disclose. 
1 
 
 Use of infrared thermography to estimate brown fat activation after a cooling protocol 





Obesity has reached epidemic proportions worldwide, and its prevalence has doubled in the last 
30 years. In contrast to the energy-storing role of white adipose tissue (WAT), brown adipose 
tissue (BAT) acts as the main site of non-shivering thermogenesis in mammals, and has been 
reported to play a major role in protection against obesity and associated metabolic alterations 
in rodents. Infrared thermography (IRT) has been proposed as a novel non-invasive, safe, 
inexpensive, and quick method to estimate BAT thermogenic activation in humans. The aim of 
this study is to determine the thermogenic activation of BAT after a cooling protocol using IRT 
in patients with severe obesity in response to two different types of bariatric surgery (BS). 
 
Methods 
Supraclavicular BAT thermogenic activation was evaluated using IRT in a cohort of 31 patients 
(50 ± 10 years-old, BMI = 44.5 ± 7.8) at baseline and 6 months after BS. Clinical parameters were 
determined at different time points. 
 
Results 
BAT thermogenic activation by IRT was increased at 6 months after laparoscopy sleeve 
gastrectomy (LSG), while patients undergoing to a roux-en-Y gastric bypass (RYGB) did not 
change their thermogenic response using the same cooling protocol. 
 
Conclusions 
Our study reports a differential effect of LSG technique compared to RYGB on BAT activation, 
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Increased body mass is associated with numerous metabolic diseases, including type 2 
diabetes (T2D). Thus, it is not surprising to find out that, concomitantly with the dramatic 
increase in obesity, T2D has become the most common metabolic disorder, being recognized as 
one of the deadliest non-communicable diseases worldwide. Nowadays, it has been estimated 
that approximately 350 million people has diabetes, representing almost 10% of the world 
population [1]. White adipose tissue (WAT) is involved in the regulation of energy balance and 
glucose homeostasis, owing to its function as a lipid-storing and endocrine organ. Numerous 
studies have demonstrated that abnormal WAT function is linked to obesity, whole body insulin 
resistance and T2D [2]. However, few studies have comprehensively addressed the effect of 
obesity and weight loss in the thermogenic capacity. 
In contrast to the energy-storing role of WAT, brown adipose tissue (BAT) acts as the 
main site of non-shivering thermogenesis in mammals due to the presence of uncoupling 
protein-1 (UCP1) in mitochondria of brown adipocytes, which uncouples mitochondrial oxidative 
processes and generates heat [3]. BAT plays a major role in protection against obesity and 
associated metabolic alterations in rodents due to its draining of glucose and lipids from 
circulation to sustain thermogenesis [4, 5]. Moreover, sustained thermogenic activation leads 
also to the so-called ‘browning’ of adipose tissue: the appearance of beige (brown adipocyte-
like) adipocytes in anatomical sites corresponding to WAT depots [6, 7]. Chronic exercise, cold 
exposure and chronic 3-adrenergic stimulation have been shown to promote browning of WAT 
in experimental models [8]. A higher capacity of browning has been directly associated with 
protection against experimental obesity and improved glucose tolerance in mice [9]. Moreover, 
BAT has been also reported to secrete endocrine regulatory factors which contribute, in addition 
to the intrinsic energy expending properties of BAT, to the healthy effects of active BAT on 
systemic metabolism [10, 11]. 
Laparoscopy sleeve gastrectomy (LSG) and Roux-en-Y gastric bypass (RYGB) are two 
types of bariatric surgery (BS), the most effective therapy to avert obesity and T2D currently 
available [12-15]. One of the consequences of BS is activation of BAT and browning of WAT, 
which is hypothesized to contribute to the increased energy expenditure, weight loss, and 
overall improvement in systemic glucose and lipid metabolism after BS [16, 17]. In 2009, several 
studies confirmed that active BAT is present in adult humans, and that, accordingly, BAT activity 
is reduced in patients with obesity [18-21]. One of the techniques currently used to quantify BAT 
is positron emission tomography with 2-deoxy-2-[fluorine-18] fluoro-D-glucose integrated with 
computed tomography (18F-FDG-PET–CT). This technique is considered the “gold-standard” to 




































































relatively invasive technique [23].  For the moment, the lack of non-invasive and low-cost 
methods to measure BAT activation before and after BS in patients makes it difficult to 
implement this parameter in the clinical practice for a better evaluation of the patients. 
In the last years, infrared thermography (IRT) has been proposed as a novel non-
invasive, safe, cheap and quick method to estimate BAT thermogenic activation in humans [24]. 
IRT uses the heat-emitting properties of BAT and the relatively superficial position of the 
supraclavicular BAT depot. A rise in supraclavicular temperatures after cold exposure has been 
demonstrated using this methodological approach, and several studies correlated IRT data 
obtained in supraclavicular skin surface with BAT activity as determined using PET scans [25-29].  
In this study, we determined for the first time the thermogenic activation of BAT after a 
hand-cold protocol using IRT in patients with severe obesity and the role of two different types 
of BS techniques. 
 
Materials and Methods 
Subject cohort and surgical interventions 
A cohort of 31 patients (19 females/12 males, aged= 50 ± 10 years-old, BMI= 44.5 ± 7.8) 
with severe obesity were included in this study, and were stratified into two groups according 
to the type of BS they underwent: 1) LSG (n= 15), in which the stomach is transected vertically 
from 5cm proximal to the pylorous up to the His’ angle, using a 36Fr bougie as a calibrator. 
Hence, more than 70% of patient’s stomach (mainly fundus and body) volume is removed 
without modifying the rest of gastrointestinal tract (GIT) [30]; 2) RYGB (n= 16), where the 
surgeons tailor a 40-60 mL gastric pouch that is anastomosed to the previously divided jejunum 
distal to the ligament of Treitz. Reconstruction of the GIT was completed in a “Y” configuration 
with a distal jejuno-jejunostomy [31]. All patients were evaluated by the same endocrinology 
specialist according to criteria formulated in Spanish Position Statement between Obesity, 
Endocrinology, Diabetes and Surgery Societies [32]. IRT, demographic and clinical data, including 
age, diabetes, and hypertension were recorded for all participants at baseline and 6 months 
after BS. 
 
Study Visits and Protocols 
For IRT acquisition, participants went to a specific room where the body area object of 
evaluation was uncovered and sat-down during 5 min in a thermoneutral ambient for 
acclimatization (24.3 ± 1.6ºC). Women were asked to move the straps of their sports bra aside, 
and any long-haired participants were asked to tie their hair up to expose the supraclavicular 




































































For the cold protocol, 3 thermal images were taken for each patient using a FLIR T420 
infrared camera (FLIR T420 Systems AB, Sweden), with a thermal sensitivity of 0.05 ºC and 
resolution set at 320 x 240 pixels. The first image was taken to an aluminum foil phantom (1 
meter away) to obtain a measurement of the reflected temperature for each set of images; in 
this moment, ambient temperature and relative humidity were registered for each set as well. 
For the second thermal image, the participants remained seated in an upright position, with 
their arms relaxed on both sides of their legs. After a calculation of optimal distances, the camera 
was placed 1 meter from the midpoint of the chair for these images. For the third image, patients 
were asked to put their left hand in cold water (17ºC) during 5 minutes to stimulate BAT 
activation, after which the thermographic picture was taken.  
Analysis of IRT 
Thermal data were extracted from IRT pictures by using a region of interest (ROI)-based 
approach. The ROIs were manually drawn in the images on the supraclavicular and sternum 
region using the FLIR ResearchIR Max software version 4.40.6.24 for windows (FLIR Systems Inc., 
North Billerica, MA, USA). All analyses were adjusted by atmospheric temperature, distance to 
the participant and relative humidity, which, as previously stated, were recorded at the 
beginning of each IRT session. Moreover, the reflected temperature was obtained by placing a 
rounded ROI on the aluminum foil phantom of the first thermal image and retaining the mean 
value (ºC) for adjustments. For all thermographic images emissivity was set at 0.98 (human skin). 
Minimum, maximum and mean values of each ROI were retained as variables. The temperature 
in the supraclavicular region was normalized by sternum region temperature for each 
participant at all time points before and after BS. 
We calculated the delta ‘Supraclavicular T - Sternum T in thermal image number 1 (0 
min) and in thermal image number 2 (5 min after cold stimulation), obtaining a value ‘ΔT0’ for 
the thermal image 1 and a value ‘ΔT5’ for the thermal image 2: 
∆𝑇(𝑠𝑐𝑟−𝑠𝑡𝑟)
0 = 𝑇𝑠𝑢𝑝𝑟𝑎𝑐𝑙𝑎𝑣𝑖𝑐𝑢𝑙𝑎𝑟 𝑎𝑟𝑒𝑎
0 − 𝑇𝑠𝑡𝑒𝑟𝑛𝑢𝑚 𝑎𝑟𝑒𝑎
0  
∆𝑇(𝑠𝑐𝑟−𝑠𝑡𝑟)
5 = 𝑇𝑠𝑢𝑝𝑟𝑎𝑐𝑙𝑎𝑣𝑖𝑐𝑢𝑙𝑎𝑟 𝑎𝑟𝑒𝑎
5 − 𝑇𝑠𝑡𝑒𝑟𝑛𝑢𝑚 𝑎𝑟𝑒𝑎
5  
After that, we calculated the delta ‘ΔT0-5min’, which gave us the value of BAT thermogenic 




We repeated this same sequence 6 months after bariatric surgery, and we compared the values 
of the capacity of BAT thermogenic activation by cold stimulus 6 months after surgery, taking 






































































Serum samples from the study participants were collected after a 12h fasting period at 
baseline and 6 months after BS. All samples were stored at -80ºC in the Biobanc of the Health 
Sciences Research Institute Germans Trias i Pujol Foundation. The Institutional Ethics 
Committee, in accordance with the Declaration of Helsinki, approved the study (PI16-025). All 
participants gave their written informed consent before the IRT and the collection of clinical 
data and samples. 
 
Human serological analysis 
Fasted glucose and insulin levels, glycated haemoglobin, lipid profile (total cholesterol, 
HDL and LDL cholesterol, and triglycerides), urea, creatinine, and c-reactive protein were 
measured in the certified core clinical laboratory at the hospital. Body mass index, waist 
circumference and blood pressure were measured by the endocrinologists and dieticians in 
charge of the patients. The Homeostatic model Assessment-insulin resistance (HOMA-IR) was 
calculated through the following formula:  












Data are presented as mean ± sem. Statistical tests were performed with GraphPad 
Prism 6.0. Normality of datasets was assessed using the Kolmogorov-Smirnoff test. Wilcoxon 
matched pairs test was used to compare delta ‘ΔT0-5min’ before and after bariatric surgery. 
Grubbs test was used to remove outliers prior to statistical analyses. P<0.05 was considered as 
the threshold of statistical significance in all analyses. 
 
Results 
BAT thermogenic capacity of patients with severe obesity increases after BS.  Evidence of higher 
effects of the LSG versus RYGB type of BS on the induction of BAT activation. 
Clinical data from patients with obesity are shown in table 1. Patients were distributed 
according to the type of surgery. As expected, both LSG and RYGB led to weight loss and 
improved metabolic profile, including glucose and triglycerides levels. The group of individuals 
operated by LSG displayed significant lower levels of glucose and glycated hemoglobin before 
the surgery compared to the RYGB group. IRT images from all participants were taken at baseline 




































































We performed a pilot study in order to select the correct time of cold stimulus, and 
pictures were taken before and at 1, 2, 3, 4, and 5 minutes since the patients put the hand in 
the cold water. We detected a marked variability at very short times between the different 
patients (Supplementary Figure S1), and considering our observations and the previous 
literature, we chose to perform 5 minutes of cold stimulus. 
Figure 1 shows a representative example of IRT images of one participant from each 
type of surgery. This figure shows the lack of thermogenic activation by cold exposure before 
surgery in both patients. At 6 months after bariatric surgery, cold exposure activated 
supraclavicular BAT in the patient from the LSG group but not in the patient from the RYGB 
group. The general data from the whole cohort of patients are shown in Figure 2, where we 
observe a significant increase of the thermogenic activity 6 months after LSG but not RYGB. 




In this study, we demonstrate for the first-time usage of IRT as a novel non-invasive 
technique to estimate BAT activation after hand-cold exposure in patients with severe obesity 
undergoing BS.  Due to IRT being a non-invasive method, a longitudinal approach could be used 
to estimate BAT activity at several time points after BS in patients with obesity.   
Patients undergoing BS are currently evaluated before surgery in different aspects 
including endocrine-metabolic status and psychological traits. However, it is still challenging to 
predict the success of surgery because of the high variability in the extent of weight loss after 
surgery. Moreover, it is known that BAT thermogenic activation inversely correlates with BMI 
[18]. According with that, we have observed that at 6 months after BS, BAT thermogenic capacity 
increases. Therefore, we propose that this parameter, obtained through a non-invasive method 
such as IRT, is worthy to be considered among the number of data that are taken into account 
to evaluate the physiological and metabolic status of patients candidates to BS. 
Interestingly, we found differences in the extent of BAT activation depending of the type 
of surgery, being patients undergoing LSG but not RYGB the ones who actually improved BAT 
activation capacity after BS. It is important to point out that RYGB has demonstrated better long-
term results in patients with diabetes [33], and due to this fact, it is accepted in the clinical 
practice that this type of surgery must be performed in patients with severe obesity and 
impaired glucose homeostasis. In our study, differences in glucose levels and glycated 
hemoglobin were found between LSG and RYGB groups at baseline. Moreover, the LSG group 




































































compared to RYGB group. Considering that BAT has demonstrated its positive role in energy 
expenditure and insulin sensitivity, contributing to a better metabolic state [4], it is tempting to 
speculate that the BAT of patients with normoglycemia would maintain a better function than 
patients with pre-diabetes or diabetes in terms of endocrine activity. It could explain, at least in 
part, the improvement in insulin sensitivity and the increase in the capacity to activate BAT after 
cold exposure observed in LSG group compared to RYGB, which might be contributing to the 
success of BS regarding weight loss. Other researchers have described BAT activation measured 
by 18F-FDG-PET–CT after a RYGB, but interestingly, a lack of hypothalamic activity was reported 
in these patients with obesity before and after the RYGB [17]. Since hypothalamic signaling to 
BAT is the main neural circuit involved in thermogenic activation of this tissue [34], a potential 
explanation is that our protocol to expose patients to cold stress (5 minutes with their hand in 
cold water) might not be enough to activate BAT thermogenesis in the RYGB group compared 
to LSG group due to this impairment of sympathetic signaling in the former set of patients. Other 
mechanisms of action (e.g. specific changes in enterokine secretion, adipokine release or 
microbiota changes) could account for the systemic effects of RYGB without involving central 
nervous BAT activation. Further studies should be developed to decipher the potential different 
effect of LSG and RYGB in the capacity to activate BAT thermogenesis. 
Despite the advantages described above, IRT-based estimation of BAT activity is not 
exempt of limitations. Some researchers have pointed out some flaws in the quantification of 
BAT activity by IRT in subjects with obesity, suggesting that the changes in the layer of 
subcutaneous fat insulation could be a confounding factor to measure BAT temperature [35]. 
Although we assume this potential limitation in our study, it is important to remark that we did 
not use basal temperature at the supraclavicular area as index of BAT activity but the individual 
capacity to increase supraclavicular temperature before and after a single bout of cold stress in 
every individual. As the fat layer is the same before and after the 5 min cold-stimulus exposure 
in each individual patient, changes in fat layer width are not expected to significantly influence 
our estimation. PET-scan-based measurement of BAT activity may have less potential limitations 
in this regard. However, using PET-scan techniques rises as well a number of concerns (e.g., 
specific type of labeled metabolite used for the assay, stress associated with the scanning 
procedures, etc.) and are obviously not feasible for dynamic repeated measuring in the same 
individual as performed in our study, which can otherwise be assessed by IRT. Moreover, the 
lack of randomization in the type of surgery and no inclusion of normal weight individuals to 
compare at the same time their thermogenic activation by IRT are also limitations of the study 




































































In conclusion, we report for the first time that IRT-based estimation of BAT thermogenic 
activity may be useful for a follow-up of patients after BS in a convenient, non-invasive manner. 
Thus, we propose that quantification of active BAT by IRT after a cold protocol may be useful in 
clinical practice as an additional measurement to evaluate the metabolic status and the 
potential success of BS in patients with obesity. Further studies including a meta-analysis to 
check potential biological and clinical associations would be necessary to establish its precise 
contribution to the clinical practice. 
 
Conflict of Interest 






























































































1) WHO. Obesity and overweight. World Health Organization; 2017. 
2) Apostolopoulos V, de Courten MP, Stojanovska L, Blatch GL, Tangalakis K, de Courten B. 
The complex immunological and inflammatory network of adipose tissue in obesity. Mol 
Nutr Food Res. 2016;60(1):43-57. doi: 10.1002/mnfr.201500272 
3) Villarroya J, Cereijo R, Villarroya F. An endocrine role for brown adipose tissue? Am J 
Physiol Endocrinol Metab. 2013;305(5):E567-572. doi: 10.1152/ajpendo.00250.2013 
4) Bartelt A, Bruns OT, Reimer R, Hohenberg H, Ittrich H, Peldschus K, Kaul MG, Tromsdorf 
UI, Weller H, Waurisch C, Eychmuller A, Gordts PL, Rinninger F, Bruegelmann K, Freund 
B, Nielsen P, Merkel M, Heeren J. Brown adipose tissue activity controls triglyceride 
clearance. Nat Med. 2011;17(2):200-205 doi: 10.1038/nm.2297. 
5) Peirce V, Vidal-Puig A. Regulation of glucose homoeostasis by brown adipose tissue. 
Lancet Diabetes Endocrinol. 2013;1(4):353-360. doi: 10.1016/S2213-8587(13)70055-X 
6) Petrovic N, Walden TB, Shabalina IG, Timmons JA, Cannon B, Nedergaard J. Chronic 
peroxisome proliferator-activated receptor gamma (PPARgamma) activation of 
epididymally derived white adipocyte cultures reveals a population of thermogenically 
competent, UCP1-containing adipocytes molecularly distinct from classic brown 
adipocytes. J Biol Chem. 2010;285(10):7153-7164. doi: 10.1074/jbc.M109.053942 
7) Wu J, Bostrom P, Sparks LM, Ye L, Choi JH, Giang AH, Khandekar M, Virtanen KA, Nuutila 
P, Schaart G, Huang K, Tu H, van Marken Lichtenbelt WD, Hoeks J, Enerback S, 
Schrauwen P, Spiegelman BM. Beige adipocytes are a distinct type of thermogenic fat 
cell in mouse and human. Cell. 2012;150(2):366-376. doi: 10.1016/j.cell.2012.05.016 
8) Wankhade UD, Shen M, Yadav H, Thakali KM. Novel Browning Agents, Mechanisms, and 
Therapeutic Potentials of Brown Adipose Tissue. Biomed Res Int. 2016;2016:2365609. 
doi: 10.1155/2016/2365609 
9) Seale P, Conroe HM, Estall J, Kajimura S, Frontini A, Ishibashi J, Cohen P, Cinti S, 
Spiegelman BM. Prdm16 determines the thermogenic program of subcutaneous white 
adipose tissue in mice. J Clin Invest. 2011;121(1):96-105. doi: 10.1172/JCI44271 
10) Villarroya F, Cereijo R, Villarroya J, Giralt M. Brown adipose tissue as a secretory organ. 
Nat Rev Endocrinol. 2017;13(1):26-35. doi: 10.1038/nrendo.2016.136 
11) Cereijo R, Sánchez-Infantes D. Brown adipose tissue and browning: More than just a 
heating device. Endocrinol Diabetes. 2017 64(4):185-187. doi: 
10.1016/j.endinu.2017.03.001 
12) Aron-Wisnewsky J, Tordjman J, Poitou C, Darakhshan F, Hugol D, Basdevant A, Aissat A, 




































































markers in subcutaneous and omental depots and after weight loss. J Clin Endocrinol 
Metab. 2009;94(11):4619-4623. doi: 10.1210/jc.2009-0925 
13) Pontiroli AE, Morabito A. Long-term prevention of mortality in morbid obesity through 
bariatric surgery: a systematic review and meta-analysis of trials performed with gastric 
banding and gastric bypass. Ann Surg. 2011;253:484-487. doi: 
10.1097/SLA.0b013e31820d98cb 
14) Poitou C, Perret C, Mathieu F, Truong V, Blum Y, Durand H, Alili R, Chelghoum N, Pelloux 
V, Aron-Wisnewsky J, Torcivia A, Bouillot JL, Parks BW, Ninio E, Clement K, Tiret L. 
Bariatric Surgery Induces Disruption in Inflammatory Signaling Pathways Mediated by 
Immune Cells in Adipose Tissue: A RNA-Seq Study. PloS one. 2015;10(5):e0125718. doi: 
10.1371/journal.pone.0125718 
15) Cummings DE, Cohen RV. Bariatric/Metabolic Surgery to Treat Type 2 Diabetes in 
Patients With a BMI <35 kg/m2. Diabetes Care. 2016;39(6):924-933. doi: 10.2337/dc16-
0350 
16) Vijgen GH, Bouvy ND, Teule GJ, Brans B, Hoeks J, Schrauwen P, van Marken Lichtenbelt 
WD. Increase in brown adipose tissue activity after weight loss in morbidly obese 
subjects. J Clin Endocrinol Metab. 2012;97(7):E1229-1233. doi: 10.1210/jc.2012-1289 
17) Rachid B, van de Sande-Lee S, Rodovalho S, Folli F, Beltramini GC, Morari J, Amorim BJ, 
Pedro T, Ramalho AF, Bombassaro B, Tincani AJ, Chaim E, Pareja JC, Geloneze B, Ramos 
CD, Cendes F, Saad MJ, Velloso LA. Distinct regulation of hypothalamic and brown/beige 
adipose tissue activities in human obesity. Int J Obes. 2015;39(10):1515-1522. doi: 
10.1038/ijo.2015.94 
18) Cypess AM, Lehman S, Williams G, Tal I, Rodman D, Goldfine AB, Kuo FC, Palmer EL, 
Tseng YH, Doria A, Kolodny GM, Kahn CR. Identification and importance of brown 
adipose tissue in adult humans. N Engl J Med. 2009;360(15):1509-1517. doi: 
10.1056/NEJMoa0810780 
19) Saito M, Okamatsu-Ogura Y, Matsushita M, Watanabe K, Yoneshiro T, Nio-Kobayashi J, 
Iwanaga T, Miyagawa M, Kameya T, Nakada K, Kawai Y, Tsujisaki M. High incidence of 
metabolically active brown adipose tissue in healthy adult humans: effects of cold 
exposure and adiposity. Diabetes. 2009;58(7):1526-1531. doi: 10.2337/db09-0530 
20) van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM, Drossaerts JM, Kemerink 
GJ, Bouvy ND, Schrauwen P, Teule GJ. Cold-activated brown adipose tissue in healthy 




































































21) Virtanen KA, Lidell ME, Orava J, Heglind M, Westergren R, Niemi T, Taittonen M, Laine 
J, Savisto NJ, Enerback S, Nuutila P. Functional brown adipose tissue in healthy adults. N 
Engl J Med. 2009;360(15):1518-1525. doi: 10.1056/NEJMoa0808949 
22) Dadson P, Hannukainen JC, Din MU, Lahesmaa M, Kalliokoski KK, Iozzo P, Pihlajamäki J, 
Karlsson HK, Parkkola R, Salminen P, Virtanen KA, Nuutila P. Brown adipose tissue lipid 
metabolism in morbid obesity: Effect of bariatric surgery-induced weight loss. Diabetes 
Obes Metab. 2018;20(5):1280-1288. doi: 10.1111/dom.13233 
23) Chen KY, Cypess AM, Laughlin MR, Haft CR, Hu HH, Bredella MA, Enerback S, Kinahan 
PE, Lichtenbelt W, Lin FI, Sunderland JJ, Virtanen KA, Wahl RL. Brown Adipose Reporting 
Criteria in Imaging STudies (BARCIST 1.0): Recommendations for Standardized FDG-
PET/CT Experiments in Humans. Cell Metab. 2016;24(2):210-222. doi: 
10.1016/j.cmet.2016.07.014 
24) Law J, Chalmers J, Morris DE, Robinson L, Budge H, Symonds ME. The use of infrared 
thermography in the measurement and characterization of brown adipose tissue 
activation. Temperature. 2018 2(2):147-161. doi: 10.1080/23328940.2017.1397085 
25) Robinson L, Ojha S, Symonds ME, Budge H. Body mass index as a determinant of brown 
adipose tissue function in healthy children. J Pediatr. 2014;164:318-322. doi: 
10.1016/j.jpeds.2013.10.005 
26) Symonds ME, Henderson K, Elvidge L. Thermal imaging to assess age related changes of 
skin temperature within the supraclavicular region co-locating with brown adipose 
tissue in healthy children. J Pediatr. 2012;161:892-898. doi: 
10.1016/j.jpeds.2012.04.056 
27) Salem V, Izzi-Engbeaya C, Coello C, Thomas DB, Chambers ES, Comninos AN, Buckley A, 
Win Z, Al-Nahhas A, Rabiner EA, Gunn RN, Budge H, Symonds ME, Bloom SR, Tan TM, 
Dhillo WS. Glucagon increases energy expenditure independently of brown adipose 
tissue activation in humans. Diabetes Obes Metab. 2016;18(1):72-81. doi: 
10.1111/dom.12585 
28) Lee P, Ho KK, Lee P, Greenfield JR, Ho KK, Greenfield JR. Hot fat in a cool man: infrared 
thermography and brown adipose tissue. Diabetes Obes Metab. 2011;13(1):92-93. doi: 
10.1111/j.1463-1326.2010.01318.x. 
29) Nirengi S, Wakabayashi H, Matsushita M, Domichi M, Suzuki S, Sukino S, Suganuma A, 
Kawaguchi Y, Hashimoto T, Saito M, Sakane N. An optimal condition for the evaluation 
of human brown adipose tissue by infrared thermography. PLoS One. 




































































30) Gagner M, Hutchinson C, Rosenthal R. Fifth International Consensus Conference: 
current status of sleeve gastrectomy. Surg Obes Relat Dis. 2016;12(4):750-756. doi: 
10.1016/j.soard.2016.01.022 
31) Kaijser MA, van Ramshorst GH, Emous M, Veeger N, van Wagensveld BA, Pierie JEN. A 
Delphi Consensus of the Crucial Steps in Gastric Bypass and Sleeve Gastrectomy 
Procedures in the Netherlands. Obes Surg. 2018;28(9):2634-2643. doi: 10.1007/s11695-
018-3219-7 
32) Sabench Pereferrer F, Dominguez-Adame Lanuza E, Ibarzabal A, Socas Macias M, Valenti 
Azcarate V, Garcia Ruiz de Gordejuela A, Garcia-Moreno Nisa F, Gonzalez Fernandez J, 
Vilallonga Puy R, Vilarrasa Garcia N, Sanchez Santos R, Sociedad Espanola de Cirugia de 
la O. Quality criteria in bariatric surgery: Consensus review and recommendations of the 
Spanish Association of Surgeons and the Spanish Society of Bariatric Surgery. Cir Esp. 
2017;95(1):4-16. doi: 10.1016/j.ciresp.2016.09.007 
33) Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Aminian A, Brethauer SA, Navaneethan SD, 
Singh RP, Pothier CE, Nissen SE, Kashyap SR, Investigators S. Bariatric Surgery versus 
Intensive Medical Therapy for Diabetes - 5-Year Outcomes. N Engl J Med. 
2017;376(7):641-651. doi: 10.1056/NEJMoa1600869 
34) Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. 
Physiol Rev. 2004;84(1):277-359. Doi: 10.1152/physrev.00015.2003 
35) Sarasniemi JT, Koskensalo K, Raiko J, Nuutila P, Saunavaara J, Parkkola R, Virtanen KA. 
Skin temperature may not yield human brown adipose tissue activity in diverse 
















































































Figures 1. Representative IRT images of 2 patients with severe obesity undergoing RYGB or 
LSG, respectively. 
IRT before RYGB at 0 minutes (A) and before RYGB at 5 minutes of cold exposure (B). IRT 6 
months after RYGB at 0 minutes (C)and 6 months after RYGB at 5 minutes of cold exposure (D). 
IRT before LSG at 0 minutes (E) and before LSG at 5 minutes of cold exposure (F). IRT 6 months 
after LSG at 0 minutes (G) and 6 months after LSG at 5 minutes of cold exposure (H).  
 
Figure 2. BAT thermogenic capacity of patients with severe obesity is increased after BS. 
Supraclavicular skin temperature corrected by sternum temperature before and 5 minutes after 
cold exposure. Thermogenic activation, measured as the difference between 5 minutes and 0 
minutes, is represented at basal time and 6 months after the RYGB (A) and SLG (B). Paired two-
tailed t-test was used. ** p< 0.01 
 
Supplementary Figure S1. Supraclavicular skin temperature measured in several times during 
5 minutes of cold stimulus. Supraclavicular skin temperature (ºC) before and 1, 2, 3, 4, and 5 






































































Table 1. Anthropometric and metabolic parameters from patients with morbid obesity before and after bariatric 
surgery.  
  
Data are shown as mean ± SD except when it is indicated. Two-tail Student’s t-test was applied to compare two 
groups, and one-way ANOVA with Tukey’s post-hoc test was used for comparisons between more than two groups. * 
indicates p<0.05 between LSG and RYGB; # indicates p<0.05 between 0-6 postsurgery. LSG: laparoscopic sleeve 
gastrectomy; RYGB: roux-en-Y gastric bypass; LDL-Cho: Low-density lipoprotein cholesterol; HDL-Cho: High-density 
lipoprotein cholesterol.  
a This parameter is the difference between the supraclavicular skin temperature measured before the cold 
stimulation and the supraclavicular skin temperature measured after 5 minutes of cold exposure. 
b This parameter is the difference between the supraclavicular skin temperature minus the sternum temperature 
measured before the cold stimulation and the supraclavicular skin temperature minus the sternum temperature 
measured after 5 minutes of cold exposure. 
 Basal 6 months Δ6-0 months 
LSG (n=15) RYGB (n=16) LSG RYGB LSG RYGB 
Age (years) 46 ± 13 53 ± 8 - - - - 
Sex (F/M) 10/5 9/7 - - - - 
Type 2 diabetes 5 9 0 0 - - 
Body mass index (kg/m2) 46 ± 9.7 42 ± 5.1 35 ± 9.0# 31 ± 5.3# -11.74 ± 2.82 -10.91 ± 1.68 
Waist circumference (cm) 136 ± 14 130 ± 11 117 ± 16# 105 ± 15# -19.25 ± 11.23 -25.96 ± 11.91 
Glucose (mg/dl) 94 ± 10 128 ± 44* 86 ± 9 90 ± 16# -7.60 ± 9.91 -36.33 ± 30.68* 
Glycated hemoglobin (%) 5.6 ± 0.38 6.2 ± 1.01* 5.3 ± 0.32 5.3 ± 0.50# -0.30 ± 0.27 -0.89 ± 0.61* 
Insulin (m.u.int./l) 11.02 ± 8.48 12.07 ± 7.32 10.38 ± 8.34 7.14 ± 4.27# -2.38 ± 9.32 -10.72 ± 17.98 
Homeostatic model assessment 
(HOMA-IR) 
2.87 ± 2.21 4.50 ± 3.99 2.54 ± 2.11 1.63 ± 1.13# -0.77 ± 2.3 -4.48 ± 6.68 
Triacylglycerides (mg/dl) 133 ± 46 130 ± 35 97 ± 39# 100 ± 33# -38.50 ± 54.37 -29.81 ± 46.28 
Total cholesterol (mg/dl) 153 ± 20 145 ± 33 181 ± 45 164 ± 34 30.00 ± 54.17 18.75 ± 51.36 
LDL -cholesterol (mg/dl) 85 ± 20 82 ± 34 113 ± 43 100 ± 30 30.50 ± 52.76 15.06 ± 46.65 
HDL-cholesterol (mg/dl) 41 ± 9 37 ± 4 48 ± 7 48 ± 22 8.41 ± 7.82 10.97 ± 22.97 
Creatinine (mg/dl) 0.91 ± 0.64 0.84 ± 0.26 0.86 ± 0.59 0.76 ± 0.18 0 ± 0.15 -0.10 ± 0.14 
Urea (mg/dl) 39.13 ± 29.09 37.06 ± 13.74 34.80 ± 24.27 35.00 ± 7.65 -4 ± 9.87 -2.06 ± 11.62 
C-reactive protein (mg/l) 8.89 ± 5.08 6.67 ± 5.17 7.12 ± 7.32 4.22 ± 3.59 -3 ± 9.79 0.11 ± 10.92 
Systolic blood pressure (mmHg) 136 ± 16 134 ± 13 - - - - 
Diastolic blood pressure 
(mmHg) 
80 ± 7 80 ± 10 - - - - 
Absolute temperature 
difference (ºC) a 
0.59 ± 0.2 0.56 ± 0.2 0.44 ± 0.1 0.58 ± 0.3 - - 
 
Relative temperature 
difference (ºC) b 
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